To the editor

Please find enclosed the current manuscript titled " Concurrent

chemoradiation with concomitant boost in muscle invasive

." TCC urinary bladder cancer

To be submitted for consideration of publication in your esteemed

.journal

There is no financial interest to report. We certify that the submission is

original work and is not under review at any other publication.

We have no conflict of interest and the article does not violate the
policies and/or procedures established by journal. We believe that the
study could be of interest to the readers of your journal, the study aims to
shed light on concomitant boost radiotherapy concurrent with cisplatin in
muscle invasive bladder cancer patients who under went neoadjuvant
chemo and maximal TURBT and can not withstand the surgical
treatment, in addition find its safety in those critical patients.
On behalf of all contributors, I will act, guarantor, and correspond with
the journal from this point onwards.
We hope that the editorial board will agree on the interest of this study.

Sincerely yours;

Corresponding author: Doaa Ali Gamal

E-mail: doaagamaal@aun.edu.eg

doaaalygamaal@gmail.com

ORCID iD: 0000-0002-8318-1884

Mobile: 00201118118806.

Zip code: 71515

Address: Clinical oncology department, Assiut university hospital, Assiut, Egypt.